Barclays’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.2M | Buy |
384,857
+13,080
| +4% | +$313K | ﹤0.01% | 1209 |
|
|
2025
Q1 | $9.24M | Sell |
371,777
-51,444
| -12% | -$1.28M | ﹤0.01% | 1065 |
|
|
2024
Q4 | $7.97M | Buy |
423,221
+17,744
| +4% | +$334K | ﹤0.01% | 1267 |
|
|
2024
Q3 | $6.1M | Sell |
405,477
-15,778
| -4% | -$237K | ﹤0.01% | 1380 |
|
|
2024
Q2 | $12.1M | Buy |
421,255
+361,479
| +605% | +$10.3M | ﹤0.01% | 847 |
|
|
2024
Q1 | $1.75M | Sell |
59,776
-25,273
| -30% | -$739K | ﹤0.01% | 2037 |
|
|
2023
Q4 | $2.87M | Buy |
85,049
+51,645
| +155% | +$1.74M | ﹤0.01% | 1913 |
|
|
2023
Q3 | $1.03M | Buy |
33,404
+1,493
| +5% | +$45.8K | ﹤0.01% | 2082 |
|
|
2023
Q2 | $1.28M | Sell |
31,911
-2,178
| -6% | -$87.2K | ﹤0.01% | 2005 |
|
|
2023
Q1 | $1.39M | Buy |
34,089
+6,671
| +24% | +$272K | ﹤0.01% | 1905 |
|
|
2022
Q4 | $1.06M | Buy |
27,418
+10,033
| +58% | +$388K | ﹤0.01% | 2081 |
|
|
2022
Q3 | $924K | Sell |
17,385
-5,520
| -24% | -$293K | ﹤0.01% | 2197 |
|
|
2022
Q2 | $1.34M | Sell |
22,905
-19,088
| -45% | -$1.11M | ﹤0.01% | 1857 |
|
|
2022
Q1 | $3.21M | Sell |
41,993
-29,759
| -41% | -$2.27M | ﹤0.01% | 1427 |
|
|
2021
Q4 | $4.32M | Buy |
71,752
+11,415
| +19% | +$687K | ﹤0.01% | 1332 |
|
|
2021
Q3 | $3.38M | Buy |
60,337
+30,373
| +101% | +$1.7M | ﹤0.01% | 1483 |
|
|
2021
Q2 | $1.82M | Sell |
29,964
-25,797
| -46% | -$1.57M | ﹤0.01% | 1777 |
|
|
2021
Q1 | $3.91M | Buy |
55,761
+993
| +2% | +$69.6K | ﹤0.01% | 1373 |
|
|
2020
Q4 | $3.28M | Buy |
54,768
+2,862
| +6% | +$171K | ﹤0.01% | 1259 |
|
|
2020
Q3 | $3.12M | Buy |
51,906
+12,721
| +32% | +$765K | ﹤0.01% | 1223 |
|
|
2020
Q2 | $2.06M | Sell |
39,185
-441
| -1% | -$23.1K | ﹤0.01% | 1458 |
|
|
2020
Q1 | $1.33M | Sell |
39,626
-24,497
| -38% | -$822K | ﹤0.01% | 1560 |
|
|
2019
Q4 | $2.9M | Buy |
64,123
+16,697
| +35% | +$756K | ﹤0.01% | 1631 |
|
|
2019
Q3 | $1.81M | Buy |
47,426
+6,833
| +17% | +$260K | ﹤0.01% | 1845 |
|
|
2019
Q2 | $1.77M | Sell |
40,593
-19,552
| -33% | -$851K | ﹤0.01% | 1911 |
|
|
2019
Q1 | $2.29M | Buy |
60,145
+53,166
| +762% | +$2.02M | ﹤0.01% | 1459 |
|
|
2018
Q4 | $300K | Sell |
6,979
-14,559
| -68% | -$626K | ﹤0.01% | 2543 |
|
|
2018
Q3 | $1.06M | Buy |
21,538
+13,627
| +172% | +$670K | ﹤0.01% | 2219 |
|
|
2018
Q2 | $254K | Sell |
7,911
-2,447
| -24% | -$78.6K | ﹤0.01% | 2630 |
|
|
2018
Q1 | $323K | Buy |
10,358
+28
| +0.3% | +$873 | ﹤0.01% | 2565 |
|
|
2017
Q4 | $473K | Sell |
10,330
-7,595
| -42% | -$348K | ﹤0.01% | 2123 |
|
|
2017
Q3 | $673K | Buy |
17,925
+12,704
| +243% | +$477K | ﹤0.01% | 1777 |
|
|
2017
Q2 | $248K | Sell |
5,221
-265,200
| -98% | -$12.6M | ﹤0.01% | 2325 |
|
|
2017
Q1 | $12.3M | Buy |
270,421
+102,201
| +61% | +$4.66M | 0.01% | 445 |
|
|
2016
Q4 | $5.43M | Buy |
168,220
+152,281
| +955% | +$4.92M | 0.01% | 722 |
|
|
2016
Q3 | $544K | Buy |
15,939
+15,916
| +69,200% | +$543K | ﹤0.01% | 1692 |
|
|
2016
Q2 | $1K | Sell |
23
-70,524
| -100% | -$3.07M | ﹤0.01% | 3441 |
|
|
2016
Q1 | $3.67M | Buy |
70,547
+36,956
| +110% | +$1.92M | 0.01% | 803 |
|
|
2015
Q4 | $2.55M | Buy |
33,591
+21,657
| +181% | +$1.64M | ﹤0.01% | 959 |
|
|
2015
Q3 | $489K | Buy |
11,934
+9,493
| +389% | +$389K | ﹤0.01% | 1734 |
|
|
2015
Q2 | $171K | Sell |
2,441
-788
| -24% | -$55.2K | ﹤0.01% | 2128 |
|
|
2015
Q1 | $284K | Sell |
3,229
-12,292
| -79% | -$1.08M | ﹤0.01% | 2143 |
|
|
2014
Q4 | $1.37M | Buy |
15,521
+1,621
| +12% | +$143K | ﹤0.01% | 1485 |
|
|
2014
Q3 | $1.34M | Sell |
13,900
-52,995
| -79% | -$5.09M | ﹤0.01% | 1546 |
|
|
2014
Q2 | $6.09M | Buy |
66,895
+20,512
| +44% | +$1.87M | 0.01% | 860 |
|
|
2014
Q1 | $3.2M | Buy |
46,383
+45,255
| +4,012% | +$3.12M | ﹤0.01% | 1128 |
|
|
2013
Q4 | $65K | Sell |
1,128
-1,052
| -48% | -$60.6K | ﹤0.01% | 3262 |
|
|
2013
Q3 | $105K | Buy |
2,180
+134
| +7% | +$6.45K | ﹤0.01% | 2921 |
|
|
2013
Q2 | $60K | Buy |
+2,046
| New | +$60K | ﹤0.01% | 3274 |
|